Acrokeratosis Verruciformis Of Hopf: Diagnosis & Treatment

Acrokeratosis verruciformis of Hopf (AKV) is a rare genodermatosis characterized by multiple flat-topped, polygonal, skin-coloured papules resembling plane warts, primarily on the dorsal aspects of hands and feet.

What is acrokeratosis verruciformis of Hopf?

Acrokeratosis verruciformis of Hopf, first described by German dermatologist August Hopf in 1931, is an uncommon disorder of keratinization. It typically manifests in early childhood, often at birth or infancy, with numerous small, firm, flat-topped papules distributed symmetrically on the backs of the hands and feet. These lesions have a distinctive polygonal shape and warty appearance, earning the condition its name, which translates to ‘wart-like condition of the extremities’.

While classically familial with autosomal dominant inheritance, sporadic non-familial cases like a 36-year-old male with hyperkeratotic whitish papules on palms have been documented. The disorder affects both sexes equally and follows a chronic course without spontaneous remission. AKV spares seborrhoeic areas such as the scalp, face, axillae, groin, and oral mucosa.

Who gets acrokeratosis verruciformis of Hopf?

AKV primarily affects individuals of all ages but onset is usually in infancy or early childhood. Familial cases show autosomal dominant transmission, though sporadic occurrences challenge this pattern. There is no racial or gender predilection.

In rare instances, late-onset presentations occur, as in a reported case of a 36-year-old without family history. Genetic predisposition via ATP2A2 mutations on chromosome 12q24 underpins most cases, overlapping with allelic variants seen in Darier disease.

What causes acrokeratosis verruciformis of Hopf?

AKV results from heterozygous mutations in the ATP2A2 gene, encoding a calcium pump ATPase in the endoplasmic reticulum. The most common is the p.Pro602Leu (P602L) missense mutation, impairing calcium homeostasis and disrupting keratinocyte differentiation.

This leads to defective keratinization, acanthosis, and hyperkeratosis. ATP2A2 mutations are allelic to Darier disease, explaining clinical overlaps, though AKV lacks dyskeratosis and acantholysis. Rare associations with HPV-17 and malignant transformation to squamous cell carcinoma exist.

What are the clinical features of acrokeratosis verruciformis of Hopf?

Classic lesions are multiple, 1–4 mm flat-topped, polygonal papules with hyperkeratotic verrucous surfaces, skin-coloured to brown. They localize to dorsal hands (proximal/distal interphalangeal joints), feet, elbows, and knees.

• Dorsal hands and feet: Symmetrical warty papules resembling verruca plana.
• Palmoplantar keratoses: Punctate hyperkeratoses, sometimes linear or diffuse.
• Nail changes: Longitudinal ridging, thickening, leukonychia (white spots).
• Trunk involvement: Flat skin-coloured to hyperpigmented macules (rare).
• Vesicles: Friction-induced on papules.

Dermoscopy reveals cobblestone white areas with uniform texture. Lesions are asymptomatic, without itch, pain, or seasonal variation.

Diagnosis

Diagnosis combines clinical features, dermoscopy, histopathology, and genetics.

Clinical diagnosis

Suspect AKV with multiple flat warty papules on dorsal extremities in childhood, plus palmoplantar/nail changes. Differentiate from:

• Verruca plana (HPV-driven, regress).
• Darier disease (greasy yellow-brown crusted papules, acantholysis).
• Epidermodysplasia verruciformis (HPV, immunosuppression).
• Lichen planus (pruritic, Wickham striae).

Dermoscopy

Cobblestone pattern with white homogeneous areas.

Histopathology

Biopsy shows hallmark ‘church spire’ pattern: circumscribed epidermal elevations with compact hyperkeratosis, acanthosis, papillomatosis, hypergranulosis, absent parakeratosis. Mild spongiosis, perivascular lymphs; no dyskeratosis/acantholysis.

Genetic testing

Confirms ATP2A2 mutations.

Differential diagnosis

Disease severity scoring

No validated score exists; clinical extent (affected sites, papule density) guides management.

Management

Treatment is challenging; no cure exists. Focus on cosmesis and complications.

• Topical therapies: Retinoids (tazarotene), keratolytics (salicylic acid, urea), calcipotriol reduce hyperkeratosis.
• Systemic retinoids: Acitretin (10–25 mg/day) for extensive disease; monitor lipids/liver.
• Other: Cryotherapy, electrosurgery, CO2 laser for localized lesions.
• Supportive: Emollients, avoid friction.

Rare squamous cell carcinoma requires excision.

Complications

• Cosmetic embarrassment, koebnerization.
• Nail dystrophy.
• Rare SCC.

Prognosis

Chronic, non-resolving; worsens with age/sun exposure. Good with treatment adherence.

Frequently Asked Questions

Is acrokeratosis verruciformis of Hopf contagious?

No, it is genetic, not infectious.

Can AKV be cured?

No cure; symptomatic management only.

Does AKV affect internal organs?

No, purely cutaneous.

Is genetic testing necessary?

Confirmatory in atypical/sporadic cases.

What is the link to Darier disease?

Allelic ATP2A2 mutations; AKV milder.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete